Search

Your search keyword '"Zhao,Chengguang"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Zhao,Chengguang" Remove constraint Author: "Zhao,Chengguang" Database MEDLINE Remove constraint Database: MEDLINE
84 results on '"Zhao,Chengguang"'

Search Results

1. Tofacitinib for child-onset systemic lupus erythematosus.

2. Prevalence and allergy-related risk factors of overactive bladder in children in Northeast China.

5. Effects of oscillatory positive expiratory pressure therapy in patients undergoing thoracic or upper abdominal surgery: A systematic review and meta-analysis.

6. Demethylzeylasteral exerts potent efficacy against non-small-cell lung cancer via the P53 signaling pathway.

7. Krüppel-like factor 4 modulates the miR-101/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial-mesenchymal transition.

8. Solamargine improves the therapeutic efficacy of anti-PD-L1 in lung adenocarcinoma by inhibiting STAT1 activation.

9. Design, synthesis, and biological evaluation of naphthoylamide derivatives as inhibitors of STAT3 phosphorylation.

10. Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway.

11. Correlation between RNA N6-methyladenosine and ferroptosis in cancer: current status and prospects.

12. CDK4/6 inhibitors in lung cancer: current practice and future directions.

13. COPA syndrome caused by a novel p.Arg227Cys COPA gene variant.

14. Gracillin relieves pulmonary fibrosis by suppressing the STAT3 axis.

15. A single-center study of clinical features of pediatric Sjögren's syndrome.

16. Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling.

17. Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway.

18. Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway.

19. The emerging role of the piRNA/PIWI complex in respiratory tract diseases.

20. Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer.

21. Study on the relationship between nephrotic syndrome and atopic diseases in childhood.

22. GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma.

23. Acetylshikonin exerts anti-tumor effects on non-small cell lung cancer through dual inhibition of STAT3 and EGFR.

24. AT7519 against lung cancer via the IL6/STAT3 signaling pathway.

26. Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling.

27. Hypocrellin A exerts antitumor effects by inhibiting the FGFR1 signaling pathway in non-small cell lung cancer.

28. Neobavaisoflavone Demonstrates Valid Anti-tumor Effects in Non-Small- Cell Lung Cancer by Inhibiting STAT3.

29. FGF/FGFR signaling: From lung development to respiratory diseases.

30. Novel TBC1D8B Variant in a 6-Month-Old Boy With Steroid-Sensitive Nephrotic Syndrome: A Case Report.

31. Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma.

32. Cyy260, a novel small molecule inhibitor, suppresses non-small cell lung cancer cell growth via JAK2/STAT3 pathway.

33. Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer.

34. A potential pathogenic role of interleukin-6 in a child with ANCA-negative pauci-immune crescentic glomerulonephritis: case report and literature review.

35. An Allergic Risk Factor Analysis of Extraordinary Daytime Only Urinary Frequency in Children.

36. Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases.

37. Case Report: Corneal Leucoma as a Novel Clinical Presentation of Nail-Patella Syndrome in a 5-Year-Old Girl.

38. Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer.

39. Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer.

40. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.

41. Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis.

42. Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway.

43. Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway.

44. Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition.

45. Silencing of the lncRNA TUG1 attenuates the epithelial-mesenchymal transition of renal tubular epithelial cells by sponging miR-141-3p via regulating β-catenin.

46. Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China.

47. Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells.

48. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.

49. Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression.

50. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.

Catalog

Books, media, physical & digital resources